跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FINGOLIMOD-TEVA fingolimod (as hydrochloride) 0.5 mg capsule blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
FINGOLIMOD-TEVA fingolimod (as hydrochloride) 0.5 mg capsule blister pack
Approved
STANDARD
FINGOLIMOD-TEVA fingolimod (as hydrochloride) 0.5 mg capsule blister pack
Teva Pharma Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
176bd7dd291ffbaa
Company
Teva Pharma Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
176bd7dd291ffbaa
Product Name
FINGOLIMOD-TEVA fingolimod (as hydrochloride) 0.5 mg capsule blister pack
Artg Id
384703
Artg Name
FINGOLIMOD-TEVA fingolimod (as hydrochloride) 0.5 mg capsule blister pack
Sponsor
Teva Pharma Australia Pty Ltd
Company Detail Path
/organization/teva-pharma-australia-pty-ltd
Artg Date
2023-01-16
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-CMI-01684-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-PI-01142-1
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
176bd7dd291ffbaa
Type
Standard
Back to TGA Approvals